Oxford University to test COVID vaccine response in children

About 300 volunteers to be enrolled in the first study on immune response in children to the AstraZeneca vaccine.

The University of Oxford has launched a study to assess the safety and immune response of the COVID-19 vaccine it has developed with AstraZeneca in children for the first time. The new mid-stage trial will determine whether the vaccine is effective for people between the ages of six and 17, according to a statement from the university on Saturday. About 300 volunteers will be enrolled and first inoculations are expected this month, Oxford said.